HIV Infection
📧 Sign up to get email alerts when something new happens for HIV Infection.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2011-05-23Clinical Trial Update: Nevirapine vs. Atazanavir Boosted With Ritonavir on a Background of Truvada in Human Immunodeficiency Virus (HIV) Infected Naive Patients (NEwArT) [Phase 4]
Phase 4 NEwArT trial comparing nevirapine to atazanavir boosted with ritonavir on a Truvada background in HIV-infected, treatment-naive pati…
-
FDA approval · 2011-05-20FDA Approved: EDURANT — Original Application (Janssen Products, LP)
The FDA approved the original application for Edurant (rilpivirine hydrochloride) from Janssen, introducing this HIV-1 antiretroviral agent …
-
FDA approval · 2011-05-19FDA Approved: ZIDOVUDINE — Supplemental Application (Aurobindo Pharma Limited)
FDA granted approval of a supplemental application for Zidovudine submitted by Aurobindo Pharma Limited. Zidovudine is an antiretroviral use…
-
CLINICAL_TRIALS trial_result · 2011-05-19Clinical Trial Update: TMC114-C201: A Study to Determine the Antiviral Activity of TMC114 in Patients With Multiple Protease Inhibitor (PI) Resistant Human Immunodeficiency Virus (HIV) Strains [Phase 2]
Phase 2 study evaluating the antiviral activity of TMC114 (darunavir) in HIV patients with multiple protease inhibitor–resistant strains; th…
-
CLINICAL_TRIALS trial_result · 2011-05-19Clinical Trial Update: TMC125-C211: Trial of TMC125 in HIV-1 Infected Subjects Who Were in a Sponsor Selected TMC125 Trial [Phase 2]
A Phase 2 trial (TMC125-C211) evaluated TMC125 in HIV-1 infected subjects who were in a sponsor-selected TMC125 trial; the study is complete…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2011-05-19Clinical Trial Update: Raltegravir With Optimized Background Therapy (OBT) in Multiple Experienced HIV-infected Patients
This clinical trial evaluated raltegravir in combination with optimized background therapy in multiple experienced HIV-infected patients; th…
-
CLINICAL_TRIALS trial_result · 2011-05-19Clinical Trial Update: An Open-Label Study to Evaluate the Effect of Every Other Week PROCRIT� (Epoetin Alfa) Dosing (40,000-60,000 Units) On Maintaining Quality of Life and Target Hemoglobin Levels in Anemic HIV-Infected Patients (CHAMPS II) [Phase 4]
Phase 4 open-label study evaluating every-other-week dosing of epoetin alfa (PROCRIT) to maintain quality of life and target hemoglobin in a…
-
CLINICAL_TRIALS trial_result · 2011-05-19Clinical Trial Update: TMC125-C227: A Phase II Randomized, Active-Controlled, Open Label Trial to Investigate the Efficacy and Tolerability of TMC125 in HIV-1 Infected Subjects, Who Are PI-Naive and With Documented Genotypic Evidence of NNRTI Resistance From Previous NNRTI Use [Phase 2]
Phase II randomized, active-controlled, open-label study evaluating etravirine (TMC125) in HIV-1 infected, protease inhibitor-naive adults w…
-
CLINICAL_TRIALS trial_result · 2011-05-19Clinical Trial Update: NATURAL HISTORY-Hepatitis C Virus/ Human Immunodeficiency Virus Coinfection [Phase 2]
Phase 2 clinical trial investigating coinfection of Hepatitis C and HIV has completed. Anemia is listed among the study conditions.
-
CLINICAL_TRIALS trial_result · 2011-05-16Clinical Trial Update: An Open Label Study To Evaluate The Safety and Kinetics of Nelfinavir in Subjects With HIV and Hepatitis C [Phase 4]
An open-label Phase 4 study evaluated the safety and pharmacokinetics of nelfinavir in subjects with HIV infection and Hepatitis C. The tria…
-
CLINICAL_TRIALS trial_result · 2011-05-16Clinical Trial Update: KALETRA Or LEXIVA With Ritonavir Combined With EPIVIR And Abacavir In Naive Subjects Over 48 Weeks [Phase 3]
A Phase 3 trial evaluating regimens of KALETRA or LEXIVA boosted with Ritonavir plus Epivir and Abacavir in HIV-naive subjects has completed…
-
CLINICAL_TRIALS research · 2011-05-16Clinical Trial Update: EuroSIDA As An External Comparator To MOTIVATE Trials
Clinical trial update describing the use of EuroSIDA as an external comparator in MOTIVATE trials for HIV treatment.
-
FDA approval · 2011-05-13FDA Approved: ZIAGEN — Supplemental Application (ViiV Healthcare Company)
FDA approved a supplemental application for Ziagen (abacavir sulfate) filed by ViiV Healthcare Company.
-
CLINICAL_TRIALS trial_result · 2011-05-13Clinical Trial Update: The Effect of Pregnancy on the Pharmacokinetics of the Kaletra Tablet [Phase 1]
A Phase 1 study evaluating how pregnancy affects the pharmacokinetics of Kaletra (lopinavir/ritonavir) tablets in individuals with HIV. The …
-
CLINICAL_TRIALS trial_result · 2011-05-13Clinical Trial Update: Study in Healthy Males to Measure Darunavir and Etravirine in Blood, Seminal Fluid, and Rectal Tissue [Phase 1]
Phase 1 study in healthy men evaluating pharmacokinetics of darunavir and etravirine in blood, semen, and rectal tissue.
-
CLINICAL_TRIALS trial_result · 2011-05-10Clinical Trial Update: Capravirine (AG1549) in Combination With Viracept and Two NRTIs in HIV Infected Patients Who Failed an Initial NNRTI Containing Regimen [Phase 2]
Pfizer conducted a Phase 2 trial of capravirine (AG1549) in combination with Viracept and two NRTIs in HIV-infected patients who failed an i…
-
CLINICAL_TRIALS trial_result · 2011-05-09Clinical Trial Update: BMS-Reyataz Study in Treatment in Naive Subjects to Compare the Efficacy and Safety Between Boosted Reyataz and Kaletra When in Combination With Fixed Dose Truvada [Phase 3]
Phase 3 trial comparing boosted atazanavir (Reyataz) to lopinavir/ritonavir (Kaletra) each with fixed-dose Truvada in treatment-naive HIV-1 …
-
FDA approval · 2011-05-06FDA Approved: KALETRA — Supplemental Application (AbbVie Inc.)
FDA approved a supplemental application for KALETRA (lopinavir/ritonavir) from AbbVie Inc.
-
CLINICAL_TRIALS trial_result · 2011-05-05Clinical Trial Update: Study of a Potential Preventive Vaccine Against HIV in Healthy Volunteers [Phase 1]
Phase 1 trial evaluating a potential preventive HIV vaccine in healthy volunteers has completed.
-
CLINICAL_TRIALS trial_result · 2011-05-04Clinical Trial Update: Safety and Effectiveness of a New Protease Inhibitor, BMS-232632, in HIV-Positive Patients Who Have Received Previous Treatment [Phase 2]
Phase 2 trial results evaluate the safety and effectiveness of BMS-232632, a protease inhibitor, in HIV-infected patients who have received …
-
CLINICAL_TRIALS trial_result · 2011-05-04Clinical Trial Update: Study of a New Protease Inhibitor, BMS-232632, in Combination With Other Anti-HIV Drugs [Phase 2]
A Phase 2 clinical trial evaluating BMS-232632, a protease inhibitor, in combination with other HIV drugs has completed.
-
CLINICAL_TRIALS trial_result · 2011-05-04Clinical Trial Update: Effectiveness and Safety of Two Forms of Stavudine in HIV-Infected Patients [Phase 3]
Phase 3 trial comparing two formulations of stavudine in HIV-infected patients to assess effectiveness and safety; the study has completed.
-
CLINICAL_TRIALS trial_result · 2011-05-04Clinical Trial Update: A Study to Evaluate the Use of Stavudine (d4T) to Treat AIDS Dementia Complex [Phase 3]
A Phase 3 clinical trial evaluating stavudine (d4T) for AIDS dementia complex has completed.
-
CLINICAL_TRIALS trial_result · 2011-05-04Clinical Trial Update: The Safety and Effectiveness of Lamivudine Plus Stavudine or Zidovudine in HIV-Infected Patients Who Have Taken Zidovudine [Phase 3]
Phase 3 trial evaluating the safety and effectiveness of lamivudine plus stavudine or zidovudine in HIV-infected patients who have previousl…
-
CLINICAL_TRIALS trial_result · 2011-05-04Clinical Trial Update: A Comparison of BMS-232632 With Efavirenz, Each in Combination With Zidovudine-Lamivudine [Phase 3]
Phase 3 trial comparing BMS-232632 with efavirenz, each combined with Zidovudine-Lamivudine, in HIV infection; the study has completed.